Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma
Open Access
- 25 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in World Journal of Surgical Oncology
- Vol. 19 (1), 1-10
- https://doi.org/10.1186/s12957-021-02268-5
Abstract
Renal cell carcinoma (RCC) is a common malignant tumour of the genitourinary system. We aimed to analyse the potential value of metastasis-related biomarkers, circulating tumour cells (CTCs) and the proliferative marker Ki-67 in the diagnosis of RCC. Data from 24 laparoscopic radical nephrectomies (RNs) and 17 laparoscopic partial nephrectomies (PNs) were collected in 2018. The numbers and positive rates of CTCs and circulating tumour microemboli (CTM) in the peripheral blood were obtained at three different time points: just before surgery, immediately after surgery and 1 week after surgery. Ki-67 protein expression was evaluated in the RCC tissue by immunohistochemistry. Except for the statistically significant association between the preoperative CTC counts and tumour size, no association between the number and positive rate of perioperative CTCs and clinicopathological features was found. The CTC counts gradually decreased during the perioperative period, and at 1 week after surgery, they were significantly lower than those before surgery. High Ki-67 expression was significantly positively correlated with preoperative CTC counts. In addition, Ki-67 expression was higher in the high CTC group (≥ 5 CTCs). Our results suggest that surgical nephrectomy is associated with a decrease in CTC counts in RCC patients. CTCs can act as a potential biomarker for the diagnosis and prognosis of RCC. A careful and sufficient long-term follow-up is needed for patients with high preoperative CTC counts.Keywords
Funding Information
- Science and Technology Project of Henan Province (162102310040)
This publication has 45 references indexed in Scilit:
- The Emerging Role of Circulating Tumor Cell Detection in Genitourinary CancerJournal of Urology, 2012
- Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic BiomarkerClinical Cancer Research, 2011
- Expression of theForkheadTranscription Factor FOXP1 is Associated with Tumor Grade and Ki67 Expression in Clear Cell Renal Cell CarcinomaCancer Investigation, 2011
- Circulating Tumor Cell Analysis: Technical and Statistical Considerations for Application to the ClinicJournal of Oncology, 2009
- Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Renal Cell Carcinoma Correlates with PrognosisCancer Epidemiology, Biomarkers & Prevention, 2009
- Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective studyBritish Journal of Cancer, 2009
- Ki‐67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each otherCancer, 2007
- Detection of circulating tumor cells in patients with renal cell carcinoma by reverse transcriptase polymerase chain reaction for G250/MNCA-9: Results of a prospective trialUrologic Oncology, 2006
- Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant DiseasesClinical Cancer Research, 2004
- Isolation by Size of Epithelial Tumor Cells: A New Method for the Immunomorphological and Molecular Characterization of Circulating Tumor CellsThe American Journal of Pathology, 2000